Innovation and Development

Innovative research and development is the cornerstone of Wanbang Biopharma’s core competitiveness!
Wanbang Biopharma invests 5% -10% of its annual operating income for drug research and development,
Nearly 300 full-time R&D technicians,
World-class R&D and production bases of prokaryotic and eukaryotic genetically engineered drugs.

R&D and Innovation

Based on efficient and high-quality R&D, Wanbang Biopharma is always committed to "affordable innovation" and solving unmet needs for disease treatment.


R&D platforms


Annual Applications for National Intellectual Patents

Explore More


Search, evaluate and introduce development opportunities worldwide. Products are exported to the countries of United States, Germany, the Netherlands, Spain, Italy, Peru, Venezuela, Thailand, Malaysia and Hong Kong and Taiwan.

Explore More